NCT00040638View on ClinicalTrials.gov

Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions

Carcinoma, Non-small-cell Lung

Interventions

DRUG

TLK286

Trial Locations (3)

77030

M.D. Anderson Cancer Center, Houston

85724

Arizona Cancer Center, Tucson

90095

UCLA Medical Center, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Telik

INDUSTRY